共 50 条
- [23] Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study" [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (09)
- [24] Very Late Restenosis of a Paclitaxel-Eluting Stent Implanted to Treat Previous In-Stent Restenosis of a Bare Metal Stent [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (09): : 1101 - 1103
- [28] Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis -: A randomized controlled trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (02): : 165 - 171
- [30] Comparison of efficacy and safety between sirolimus-eluting stent (Cypher™) and paclitaxel-eluting stent (TAXUS™) on the outcome of patients with diffuse in-stent restenosis [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 96H - 96H